Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07034339Recruiting
Immune map for pancreatic cancer evolution
This study builds an immune map of how pancreatic cancer changes over time. It may help doctors better understand the disease and find new treatment strategies.
Hangzhou, ZhejiangAges 18–80 - NCT07035418Recruiting
Young adults' role in cancer care decisions
This study looks at how much young people with cancer (ages 15–29) want to be involved in making decisions about their care. It's for those currently on treatment, at end of life, or who finished treatment up to a year ago.
Palo Alto, CaliforniaAges 15–29 - NCT07036107Recruiting
Exoskeleton rehab for spinal cord injury in Spain
This trial tests whether a wearable exoskeleton can help people with recent spinal cord injury improve their walking ability and quality of life. It focuses on patients treated in the Spanish healthcare system.
Toledo, Castille-La ManchaAges 18–70 - NCT07036250RecruitingPhase 1/Phase 2
Study of U32 for acute myeloid leukemia
This trial tests a new treatment called U32 for people with acute myeloid leukemia (AML) that has come back or not responded to prior therapy. It aims to see if targeting certain proteins on leukemia cells can help control the disease.
SuzhouAges 2–65 - NCT07037238RecruitingPhase 2
Everolimus for treating vascular malformations
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
BeijingAges 18–65 - NCT07039071Recruiting
Laceback study for orthodontic treatment outcomes
This trial tests whether a technique called laceback improves treatment results for people getting braces. It looks at tooth movement and patient comfort.
Kuantan, PahangAges 15 years+ - NCT07039097Recruiting
Surgery for uterine septum to improve natural pregnancy
This trial tests if removing a uterine septum (a wall-like tissue inside the womb) through a minimally invasive procedure helps women who have not had repeated miscarriages get pregnant naturally. You would be randomly assigned to have the surgery or not, and your pregnancy outcomes would be tracked.
Changsha, HunanAges 20–40 - NCT07039253Recruiting
Dating violence prevention program for teens and parents
This study tests a program during a regular check-up that helps teens and their parents learn about healthy relationships and prevent dating violence. It takes place at a primary care clinic and involves both you and your teen.
Monongahela, PennsylvaniaAges 12 years+ - NCT07039617Recruiting
Testing a new insulin delivery algorithm at home for type 1 diabetes
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
Charlottesville, VirginiaAges 18 years+ - NCT07040306Recruiting
Follow-up study on drug therapy for Graves' disease
This study looks at how well medication works for people with Graves' disease in China. It may help doctors understand the best treatment options for both new cases and relapses.
Shenyang, LiaoningAges 18 years+ - NCT07040475Recruiting
Effects of integrative medicine during hospital stays
This study looks at how traditional, complementary, and integrative medicine (like acupuncture, herbal remedies, or mind-body therapies) affects patients during their hospital stay. Researchers want to see if these approaches help with recovery or comfort.
BambergAges 18 years+ - NCT07040891Recruiting
Testing a program to boost breast cancer trial talks
This study is testing a program called 'Just ASK' that helps cancer care teams talk to patients about clinical trials. The researchers want to see if the program increases how often patients discuss and consider joining a breast cancer trial.
Plainsboro, New JerseyAges 18 years+ - NCT07041073Recruiting
Brain training for emotion control in depression
This trial tests if a non-invasive brain training technique called neurofeedback can help people with major depression improve how they manage emotions. You participate by doing computer tasks while your brain activity is measured and shown back to you, teaching you to regulate your emotions better.
Sabadell, Barcelona, CataluñaAges 18–65 - NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
Greenfield Park, QuebecAges 55–90 - NCT07041489Recruiting
Supplement and serum for hair growth in women with thinning hair
This trial tests whether a combination of a dietary supplement and a topical serum can help women with thinning hair grow thicker, fuller hair. It's designed for women who have noticed mild to moderate hair thinning and want a non-invasive approach.
Birmingham, AlabamaAges 28–65 - NCT07041905Recruiting
Comparing two ways to treat deep cavities in back teeth
This study compares two ways of removing deep tooth decay to see which keeps the tooth nerve healthy and causes less pain afterward. It's for people who have two deep cavities on opposite sides of their mouth and want to help find the best treatment.
AdanaAges 15–55 - NCT07042802RecruitingPhase 1/Phase 2
LBL-024 plus paclitaxel for platinum-resistant ovarian cancer
This trial tests a new drug (LBL-024) combined with the chemotherapy paclitaxel for people whose ovarian cancer no longer responds to platinum-based treatments. The goal is to see if the combination can help shrink or slow the cancer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07043322RecruitingPhase 2
Cabergoline vs coasting for OHSS prevention
This study tests whether a medicine called cabergoline can lower the chance of ovarian hyperstimulation syndrome (OHSS) in women undergoing IVF who are at high risk. It compares cabergoline with a standard technique called 'coasting' (stopping fertility drugs for a few days).
Damietta, New DamiettaAges 20–35 - NCT07043569Recruiting
Strength training with blood flow restriction after ACL surgery
This trial tests a special type of strength training that uses a blood pressure cuff to limit blood flow during exercises. It aims to help people recover muscle strength and improve knee function after ACL surgery.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07044297RecruitingPhase 3
A study of a new long-acting shot to prevent HIV
This study tests an investigational long-acting shot (MK-8527) to prevent HIV. It is for HIV-negative people who are at higher risk through anal sex without condoms, and who have not used other long-acting HIV prevention before.
Birmingham, AlabamaAges 16 years+ - NCT07044310RecruitingPhase 2
Probiotics for preventing bone loss during breast cancer hormone therapy
This trial tests if a probiotic supplement can help prevent bone loss in women with HR-positive breast cancer who are starting an aromatase inhibitor. You would take the probiotic daily and provide blood and stool samples to see how it affects your bone health.
Jacksonville, FloridaAges 18 years+ - NCT07047560RecruitingPhase 2
A new chemo combo for advanced colorectal cancer
This trial tests a different way of giving a chemotherapy drug called irinotecan, along with two other drugs (5-FU and bevacizumab), for people whose cancer got worse after first-line treatment. It aims to see if this combination can help control the cancer.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07047872Recruiting
3D-printed breast form study for women after mastectomy
This study tests a custom 3D-printed external breast form for people who had a mastectomy without reconstruction. It aims to see if it improves comfort and satisfaction.
Rochester, MinnesotaAges 18 years+ - NCT07049055RecruitingPhase 1/Phase 2
EDV nanocell therapy with chemo for advanced pancreatic cancer
This trial tests a new targeted therapy (EDV nanocells) combined with two standard chemotherapy drugs for people with metastatic pancreatic cancer. It is for patients whose cancer has progressed after first-line FOLFIRINOX or NALIRIFOX treatment.
El Segundo, CaliforniaAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.